OPEN-SOURCE SCRIPT
تم تحديثه CDC ATR Trailing Stop V2.1 (2013)
CDC ATR Trailing Stop V2.1
The indicator / system was developed a few years ago.
Contains two ATR trailing stop lines, fast and slow.
The slow ATR SL line is the same as the one in a normal ATR trailing stop loss indicator.
The fast one is created to generate buy/sell signals
To use the signals, activate them from the indicator's settings (gear icon next to the indicator's name on the chart) and enable buy / sell arrows.
The system works well in high volatility market.
I personally use this as the faster system in conhunction with my slower MA system to diversify portfolio performance.
The indicator / system was developed a few years ago.
Contains two ATR trailing stop lines, fast and slow.
The slow ATR SL line is the same as the one in a normal ATR trailing stop loss indicator.
The fast one is created to generate buy/sell signals
To use the signals, activate them from the indicator's settings (gear icon next to the indicator's name on the chart) and enable buy / sell arrows.
The system works well in high volatility market.
I personally use this as the faster system in conhunction with my slower MA system to diversify portfolio performance.
ملاحظات الأخبار
Added Alert Conditions and Line IDملاحظات الأخبار
Bug fix so it is usable.نص برمجي مفتوح المصدر
بروح TradingView الحقيقية، قام مبتكر هذا النص البرمجي بجعله مفتوح المصدر، بحيث يمكن للمتداولين مراجعة وظائفه والتحقق منها. شكرا للمؤلف! بينما يمكنك استخدامه مجانًا، تذكر أن إعادة نشر الكود يخضع لقواعد الموقع الخاصة بنا.
إخلاء المسؤولية
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
نص برمجي مفتوح المصدر
بروح TradingView الحقيقية، قام مبتكر هذا النص البرمجي بجعله مفتوح المصدر، بحيث يمكن للمتداولين مراجعة وظائفه والتحقق منها. شكرا للمؤلف! بينما يمكنك استخدامه مجانًا، تذكر أن إعادة نشر الكود يخضع لقواعد الموقع الخاصة بنا.
إخلاء المسؤولية
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.